Enzo Biochem Inc (NYSE:ENZ)

6.55
Delayed Data
As of May 21
 +0.07 / +1.08%
Today’s Change
5.35
Today|||52-Week Range
12.04
-19.63%
Year-to-Date

Five Year Financial Summary

Total Revenue

Cash & Short Term Investments

Cash From Operations

All Currency in US Dollars4 Year
Trend

2014

2015

2016

2017
Operating ActivitiesNet Income / Starting Line-10.0M-2.3M45.3M-2.5M
 
 
 
 
 
Depreciation4.0M3.8M3.8M3.6M
 
 
 
 
 
Total Other Cash Flow4.0M4.0M3.9M3.9M
 
 
 
 
 
Funds From Operations-2.0M5.4M53.0M4.9M
 
 
 
 
 
Funds From/For Other Operating Expenses-338.0K9.1M-133.0K5.2M
 
 
 
 
 
Net Cash Flow - Operating Activities-1.7M-3.7M53.1M-205.0K
 
 
 
 
 
 
InvestingCapital Expenditures-838.0K-1.8M-1.5M-1.8M
 
 
 
 
 
Other Investing - Sources5.0K31.0K18.0K4.0K
 
 
 
 
 
Net Cash Flow Investing-833.0K-1.8M-1.5M-1.7M
 
 
 
 
 
 
FinancingShort Term Borrowings-251.0K0.00-1.5M-1.6M
 
 
 
 
Long Term Borrowings0.000.00------
Long Term Debt Reduction-374.0K-463.0K-565.0K-566.0K
 
 
 
 
 
Net Proceeds Stock Sale11.5M6.7M90.0K453.0K
 
 
 
 
 
Common Preferred Redeemed0.000.000.000.00--
Common Dividends0.000.000.00----
Cash Dividends Paid - Total0.000.000.00----
Other Sources - Financing0.000.000.000.00--
Other Uses - Financing0.000.000.000.00--
Net Cash Flow - Financing10.9M6.2M-1.9M-1.7M
 
 
 
 
 
 
Exchange RateEffect of Exchange Rate on Cash61.0K-119.0K-15.0K13.0K
 
 
 
 
 
 
Net Change In Cash8.4M773.0K49.7M-3.6M